Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Cited by papers we hold 17

• Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy · 2024
  Corrected
• Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system · 2023
  No notice
• Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance · 2021
  No notice
• Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective · 2020
  No notice
• CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future · 2020
  No notice
• CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off‐Target Evaluation, and Strategies to Mitigate Off‐Target Effects · 2020
  No notice
• Gene editing and CRISPR in the clinic: current and future perspectives · 2020
  No notice
• Mitochondria transfer enhances proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cell and promotes bone defect healing · 2020
  No notice
• Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning · 2019
  No notice
• Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations · 2019
  No notice
• CRISPR-Cas9 ribonucleoprotein-mediated co-editing and counterselection in the rice blast fungus · 2018
  No notice
• In utero nanoparticle delivery for site-specific genome editing · 2018
  No notice
• CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters · 2018
  No notice
• High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis · 2018
  No notice
• In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease · 2017
  No notice
• DNA-Free Genetically Edited Grapevine and Apple Protoplast Using CRISPR/Cas9 Ribonucleoproteins · 2016
  No notice
• Genome-Wide Assessment of Efficiency and Specificity in CRISPR/Cas9 Mediated Multiple Site Targeting in Arabidopsis · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.